Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-25

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for a generic Losartan Potassium product from Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)